Physician

Harsha A. Sen, M.D.

According to 2025 Medicare claims, Harsha Sen, M.D. (NPI: 1255692414) practices ophthalmology in the Dothan, AL market, with the plurality of this provider's patient population coming from Houston, AL. This provider's primary affiliated billing organization is EYE PARTNERS PC (NPI: 1902837453; TIN: 63-1232935) and primary practice location at 36301-2039.

Sen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 772 traditional Medicare patients, billed 19,638 HCPCS/CPT codes, and received $1,314,401 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,299 prescription claims across 300 beneficiaries totaling $60,298 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 26 records totaling $585. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $650,739 to $1,314,401. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $22,176 to $60,298. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$657K$1.3M2015 Medicare payment: $650,739 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $693,649 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $773,612 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $643,352 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $925,590 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $896,978 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,091,844 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $976,349 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $919,088 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,314,401 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154243,631$650,739
20164914,475$693,649
20176775,034$773,612
20189085,399$643,352
20199145,910$925,590
20207605,025$896,978
20218276,216$1,091,844
20228116,640$976,349
202375311,484$919,088
202477219,638$1,314,401

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$42K$84K2015 Drug cost: $22,176 (USD; Tot_Drug_Cst)2016 Drug cost: $22,322 (USD; Tot_Drug_Cst)2017 Drug cost: $28,603 (USD; Tot_Drug_Cst)2018 Drug cost: $61,943 (USD; Tot_Drug_Cst)2019 Drug cost: $76,269 (USD; Tot_Drug_Cst)2020 Drug cost: $73,149 (USD; Tot_Drug_Cst)2021 Drug cost: $83,580 (USD; Tot_Drug_Cst)2022 Drug cost: $62,692 (USD; Tot_Drug_Cst)2023 Drug cost: $63,634 (USD; Tot_Drug_Cst)2024 Drug cost: $60,298 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201598362$22,176
2016114368$22,322
2017128444$28,603
2018222865$61,943
2019218821$76,269
2020222843$73,149
2021224800$83,580
2022252924$62,692
20232561,093$63,634
20243001,299$60,298

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye170707$86
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more269370$79
92014Established patient complete exam of visual system496644$76
92134Imaging of retina4401,038$27
92250Photography of the retina423522$24

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate39810,755$12,929
LumiganBimatoprost211,171$10,415
SimbrinzaBrinzolamide/Brimonidine Tart321,054$6,530
ProlensaBromfenac Sodium13500$4,582
Ketorolac TromethamineKetorolac Tromethamine1705,498$3,880

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.26$585ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Harsha A. Sen, M.D.?

Tedicare shows public-source Medicare data for Harsha A. Sen, M.D. (NPI 1255692414), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Harsha A. Sen, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Harsha A. Sen, M.D.?

Harsha A. Sen, M.D. is linked to EYE PARTNERS PC (billing NPI 1902837453) in the available physician profile data.

Does Harsha A. Sen, M.D. have Open Payments data?

Harsha A. Sen, M.D. has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.